Publications
29
Citations
3,615
Est. group size
~3
Recurring co-author estimate
Active years
10
Publishing since 2016
Yuan Pu's research centers on how SARS-CoV-2 infects human cells and how this process can be blocked with drugs, using large-scale screening approaches such as siRNA (gene-silencing) screens, drug repurposing surveys, and metabolic modeling to identify host factors and antiviral targets. Work has appeared in high-profile journals like Nature, Cell, and Molecular Cell, often as part of larger collaborative teams. A few publications outside this core area (e.g., robotics, chemical engineering, AI documentation tools) suggest occasional interdisciplinary or collaborative side projects.
Publication output surged in 2020-2021 during the COVID-19 pandemic, then declined and became more sporadic in subsequent years, with a modest uptick in 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection
PLoS Biology · 2025
- Data mining and analysis of adverse events of Vedolizumab based on the FAERS database
Scientific Reports · 2025
- The potential of construction robotics to reduce airborne virus transmission in the construction industry in the UK and China
Heliyon · 2024
- Customized Retrieval Augmented Generation and Benchmarking for EDA Tool Documentation QA
arXiv (Cornell University) · 2024
- Polygonal mesopores microflower catalysts for the catalytic oxidation of 2-nitro-4-methylsulfonyltoluene to 2-nitro-4-methylsulfonylbenzoic acid in a continuous-flow microreactor
Chinese Journal of Chemical Engineering · 2024
- SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
PLoS Biology · 2022
- Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity
ACS Infectious Diseases · 2022
- Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
iScience · 2022
- MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
Cell Reports · 2021
- Functional landscape of SARS-CoV-2 cellular restriction
Molecular Cell · 2021
- Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
Nature · 2021
- Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
Molecular Systems Biology · 2021
- The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection
bioRxiv (Cold Spring Harbor Laboratory) · 2021
- Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
bioRxiv (Cold Spring Harbor Laboratory) · 2021
- Synthetic Lethality-Based Prediction of Anti-SARS-CoV-2 Targets
SSRN Electronic Journal · 2021
- bioRxiv (Cold Spring Harbor Laboratory)×5
- SSRN Electronic Journal×3
- Nature×2
- PLoS Biology×2
- Cell×1
- Shan‐Lu Liu
Medicine · The Ohio State University
- Jingyou Yu
Medicine · The Ohio State University
- Hadi M. Yassine
Medicine · Indiana University
- Cong Zeng
Medicine · The Ohio State University
- Jaffar A. Al‐Tawfiq
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile